Reading and Resources

American Cancer Society. Breast cancer facts & figures. https://www.cancer.org/research/cancer-facts-statistics/breast-cancer-facts-figures.html
Breastcancer.org. Breast cancer facts and statistics. http://www.breastcancer.org/symptoms/understand_bc
Centers for Disease Control and Prevention (CDC). Breast cancer basics. https://www.cdc.gov/breast-cancer/about/index.html
National Cancer Institute. Breast Cancer – Patient Version. https://www.cancer.gov/types/breast

Brufsky A, Maculaitis MC, Kopenhafer L, et al. Identifying drivers of first-line HR+/HER2- metastatic breast cancer treatment choices. Future Oncol. 2024;20(29):2165-2177.
Das A, Lavanya KJ, Nandini, et al. Effectiveness of selective estrogen receptor modulators in breast cancer therapy: an update. Curr Med Chem. 2023;30:3287-3314.
Feng Y, Spezia M, Huang S, et al. Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018;5(2):77-106.
Giaquinto AN, Sung H, Newman LA, et al. Breast cancer statistics 2024. CA Cancer J Clin. 2024;74(6):477-495.
Jerzak KJ, Bouganim N, Brezden-Masley C, et al. HR+/HER2- advanced breast cancer treatment in the first-line setting: expert review. Curr Oncol. 2023;30(6):5425-5447.
Kida K, Olver I, Yennu S, et al. Optimal supportive care for patients with metastatic breast cancer according to their disease progression phase. JCO Oncol Pract. 2021;17(4):177-183.
Menon G, Alkabban FM, Ferguson T. Breast cancer. 2024. In: StatPearls [internet]. https://www.ncbi.nlm.nih.gov/books/NBK482286/.
Smolarz B, Nowak AZ, Romanowicz H. Breast cancer: epidemiology, classification, pathogenesis and treatment: review of literature. Cancers (Basel). 2022;14(10):2569.

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers